DCM
AGN.PRA

Dinsmore Capital Management’s Allergan plc AGN.PRA Stock Holding History

Dinsmore Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$4.35M Buy
+4,600
New +$4.8M 1.89% 2

Other funds holding AGN.PRA

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Dinsmore Capital Management's AGN.PRA Position: Q3 2015 in Review

Dinsmore Capital Management opened a new position in Allergan plc (AGN.PRA) in Q3 2015: 4,600 shares worth $4.35M. The stake represents 1.89% of the portfolio and ranks #2 among its holdings.

99 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2015.

  • Dinsmore Capital Management held 4,600 shares of Allergan plc worth $4.35M as of Q3 2015.
  • Allergan plc was a new Dinsmore Capital Management position in Q3 2015.
  • Allergan plc made up 1.89% of Dinsmore Capital Management's portfolio in Q3 2015, its #2 holding.
  • 99 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Dinsmore Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.